)
)
Athenex Investor Relations Material
Latest events
Q3 2022
Athenex
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Athenex Inc
Access all reports
Athenex, Inc. is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel cancer therapies. The company operates through two primary segments: the Oncology Innovation Platform and the Commercial Platform. Its research and development efforts are centered around proprietary cell therapy technologies, including its Natural Killer T-cell (NKT) therapy, aimed at treating cancer. Athenex also manages a commercial division that markets specialty pharmaceutical products, particularly in oncology and related fields. The company is headquartered in Buffalo, New York, and its shares are listed on the OTC market.
Latest articles
)
Intel: Semiconductors & Strategic Inflection Points
Founded in 1968, Intel has been a key player in the American semiconductor industry, with its processors powering computers worldwide.
15 Oct 2024
)
Our Favorite Spin-off Stories Since 2000
Spin-off motives vary widely across different companies, but the underlying objective remains the same: enhancing long-term shareholder value.
17 Oct 2024
)
Walmart: Walton, Retailing, and Everyday Low Prices
Walmart was founded in 1962 by Sam Walton, and has grown to become the largest retailer in the world, employing more than 2.1 million people worldwide.
17 Oct 2024
Ticker symbol
ATNX
Country
đșđž United States